达比加群酯甲磺酸盐
Tier B — Position earlyDabigatran Etexilate Mesylate
Targets:PT
Brand:Pradaxa、Prazaxa、泰毕全、Rendix、Pradax
Indications (approved):静脉血栓栓塞、栓塞、中风、缺血性卒中、肺栓塞、静脉血栓形成
Regional status
Synthetic routes & intermediates7 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

| Code | CAS No. | Intermediate |
|---|---|---|
| DABI-001 | 41263-74-5Available | 4-(methylamino)-3-nitrobenzoic acid |
| DABI-002 | 82357-48-0Available | 4-(methylamino)-3-nitrobenzoyl chloride |
| DABI-003 | 103041-38-9Available | ethyl 3-(pyridin-2-ylamino)propanoate |
| DABI-004 | 429659-01-8Available | ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate |
| DABI-005 | 212322-56-0Available | ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |
| DABI-006 | 42288-26-6Available | 2-((4-cyanophenyl)amino)acetic acid |
| DABI-007 | 211915-84-3Available | ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| DABI-008 | 1354727-65-3Available | ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride |
| DABI-009 | - | ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride |
| DABI-010 | 6092-54-2Available | hexyl carbonochloridate |

| Code | CAS No. | Intermediate |
|---|---|---|
| DABI-003 | 103041-38-9Available | ethyl 3-(pyridin-2-ylamino)propanoate |
| DABI-004 | 429659-01-8Available | ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate |
| DABI-011 | 96-99-1Available | 4-chloro-3-nitrobenzoic acid |
| DABI-012 | 38818-50-7Available | 4-chloro-3-nitrobenzoyl chloride |
| DABI-013 | 1620205-04-0Available | ethyl 3-(4-chloro-3-nitro-N-(pyridin-2-yl)benzamido)propanoate |

| Code | CAS No. | Intermediate |
|---|---|---|
| DABI-005 | 212322-56-0Available | ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |
| DABI-010 | 6092-54-2Available | hexyl carbonochloridate |
| DABI-014 | 873-74-5Available | 4-aminobenzonitrile |
| DABI-015 | - | (Z)-4-amino-N'-hydroxybenzimidamide |
| DABI-016 | 864680-71-7Available | 3-(4-aminophenyl)-1,2,4-oxadiazol-5(4H)-one |
| DABI-017 | 105-36-2Available | ethyl 2-bromoacetate |
| DABI-018 | 872728-83-1Available | ethyl (4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl)glycinate |
| DABI-019 | 872728-82-0Available | (4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl)glycine |
| DABI-020 | 872728-84-2Available | ethyl 3-(1-methyl-2-(((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl)amino)methyl)-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| DABI-021 | - | ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |

| Code | CAS No. | Intermediate |
|---|---|---|
| DABI-005 | 212322-56-0Available | ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |
| DABI-010 | 6092-54-2Available | hexyl carbonochloridate |
| DABI-022 | 541-88-8Available | 2-chloroacetic anhydride |
| DABI-023 | 1307233-94-8Available | ethyl 3-(2-(chloromethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| DABI-024 | 1307233-93-7Available | hexyl (E)-(amino(4-aminophenyl)methylene)carbamate hydrochloride |
| DABI-025 | 2498-50-2Available | 4-aminobenzimidamide dihydrochloride |

| Code | CAS No. | Intermediate |
|---|---|---|
| DABI-005 | 212322-56-0Available | ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |
| DABI-024 | 1307233-93-7Available | hexyl (E)-(amino(4-aminophenyl)methylene)carbamate hydrochloride |
| DABI-026 | 13094-51-4Available | 2-bromoacetic anhydride |
| DABI-027 | - | ethyl 3-(3-(2-bromoacetamido)-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |

| Code | CAS No. | Intermediate |
|---|---|---|
| DABI-001 | 41263-74-5Available | 4-(methylamino)-3-nitrobenzoic acid |
| DABI-002 | 82357-48-0Available | 4-(methylamino)-3-nitrobenzoyl chloride |
| DABI-003 | 103041-38-9Available | ethyl 3-(pyridin-2-ylamino)propanoate |
| DABI-004 | 429659-01-8Available | ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate |
| DABI-005 | 212322-56-0Available | ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |
| DABI-006 | 42288-26-6Available | 2-((4-cyanophenyl)amino)acetic acid |
| DABI-007 | 211915-84-3Available | ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| DABI-010 | 6092-54-2Available | hexyl carbonochloridate |
| DABI-011 | 96-99-1Available | 4-chloro-3-nitrobenzoic acid |
| DABI-028 | 74-11-3Available | 4-chlorobenzoic acid |
| DABI-029 | - | ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| DABI-030 | - | ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate oxalate |

| Code | CAS No. | Intermediate |
|---|---|---|
| DABI-005 | 212322-56-0Available | ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate |
| DABI-010 | 6092-54-2Available | hexyl carbonochloridate |
| DABI-017 | 105-36-2Available | ethyl 2-bromoacetate |
| DABI-031 | 619-72-7Available | 4-nitrobenzonitrile |
| DABI-032 | - | (Z)-N'-hydroxy-4-nitrobenzimidamide |
| DABI-033 | 25283-96-9Available | 5-methyl-3-(4-nitrophenyl)-1,2,4-oxadiazole |
| DABI-034 | 10185-68-9Available | 4-(5-methyl-1,2,4-oxadiazol-3-yl)aniline |
| DABI-035 | 253796-85-9Available | ethyl (4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)glycinate |
| DABI-036 | 253796-86-0Available | (4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)glycine |
| DABI-037 | 1411034-23-5Available | ethyl 3-(1-methyl-2-(((4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)amino)methyl)-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| DABI-038 | 872728-85-3Available | ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate 4-methylbenzenesulfonate |
Frequently asked questions
What are the approved indications of Dabigatran Etexilate Mesylate?
Approved indications include: 静脉血栓栓塞, 栓塞, 中风, 缺血性卒中, 肺栓塞, 静脉血栓形成.
When does the Dabigatran Etexilate Mesylate patent expire?
No public expiry year is available for Dabigatran Etexilate Mesylate yet; this page updates once verified.
How many synthesis routes are recorded for Dabigatran Etexilate Mesylate?
7 synthesis routes are recorded; the shortest is 2 steps with 57.2 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Dabigatran Etexilate Mesylate intermediates?
31 intermediate CAS of Dabigatran Etexilate Mesylate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Dabigatran Etexilate Mesylate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24